Mitotic index and ki-67 nuclear antigen labeling index as predictors of chemotherapy response in uterine cervical carcinoma.

OBJECTIVE The aim of this study was to determine if the mitotic index (MI) and the Ki-67 nuclear antigen labeling index (Ki67LI) obtained from biopsy specimens could be used as predictors of chemotherapy response in uterine cervical carcinomas. METHODS Six patients with squamous cell carcinoma who received neoadjuvant chemotherapy before radical surgery were entered into the study. The MI and the Ki67LI were evaluated using hematoxylin and eosin (H&E)-stained and immunostained slides before and after chemotherapy. Tumor size was measured three-dimensionally by magnetic resonance imaging. We compared the values of MI and Ki67LI with changes in tumor size. RESULTS The cases were classified according to the percentage reduction in tumor mass: one case showed a marked response (98%), four showed a moderate response (53-78%), and one showed a slight response (approximately 0%). In the case with a marked response, the MI values before chemotherapy and 3 and 7 days after chemotherapy were 15, 2, and 0, respectively. The corresponding Ki67LI values were 51, 16, and 0, respectively. In the moderate response cases, the corresponding MI values before and 3 and 7 days after chemotherapy were 3.9-13.6, 0.8-1.6, and 1.6-4.0, respectively. The Ki67LI was 21.8-44.2 before chemotherapy, with two cases increasing and two decreasing at 7 days after chemotherapy. In the case showing a slight response, the MI values before chemotherapy and 3 and 7 days after chemotherapy were 0.5, 0.8, and 1.0, respectively. The Ki67LI was 4.0 before chemotherapy and increased slightly to 6.0 at 7 days after chemotherapy. CONCLUSIONS In six cases examined, high MI and Ki67LI values before chemotherapy and a marked decrease in MI shortly after chemotherapy appeared to be predictors of good neoadjuvant chemotherapy response in uterine cervical carcinomas.

[1]  C. Gilks,et al.  Mitotic arrest of endometrial epithelium after paclitaxel therapy for breast cancer. , 2000, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[2]  P. Pynsent,et al.  Tumour volume as a predictor of necrosis after chemotherapy in Ewing's sarcoma. , 1999, The Journal of bone and joint surgery. British volume.

[3]  T. Nakano,et al.  Correlation of cervical carcinoma c‐erb B‐2 oncogene with cell proliferation parameters in patients treated with radiation therapy for cervical carcinoma , 1997, Cancer.

[4]  S. Ferrari,et al.  The effect of intra-arterial versus intravenous cisplatinum in the neoadjuvant treatment of osteosarcoma of the limbs: the experience at the Rizzoli Institute. , 1996, La Chirurgia degli organi di movimento.

[5]  J. Hendry,et al.  Apoptosis, intrinsic radiosensitivity and prediction of radiotherapy response in cervical carcinoma. , 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  T. Nakano,et al.  Differential values of ki‐67 index and mitotic index of proliferating cell population. An assessment of cell cycle and prognosis in radiation therapy for cervical cancer , 1993, Cancer.

[7]  S. Ferrari,et al.  Effect of intra-arterial versus intravenous cisplatin in addition to systemic adriamycin and high-dose methotrexate on histologic tumor response of osteosarcoma of the extremities. , 1992, Journal of chemotherapy.

[8]  K. Oka,et al.  Transition of ki‐67 index of uterine cervical tumors during radiation therapy. Immunohistochemical study , 1991, Cancer.

[9]  T. Nakano,et al.  Immunohistochemical prediction of radiation response and local control in radiation therapy for cervical cancer. , 1998, Cancer detection and prevention.